Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Kidney transplantation in the dog receiving FK-506.

× No keyword cloud information.

11 in total

1. Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.

Authors: A C Tsamandas; S M Pham; E C Seaberg; O Pappo; R L Kormos; A Kawai; B P Griffith; A Zeevi; R Duquesnoy; J J Fung; T E Starzl; A J Demetris
Journal: J Heart Lung Transplant Date: 1997-07 Impact factor: 10.247

2. Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.

Authors: J J Fung; S Todo; A Jain; J McCauley; M Alessiani; C Scotti; T E Starzl
Journal: Transplant Proc Date: 1990-02 Impact factor: 1.066

3. Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation.

Authors: D H Van Thiel; M Iqbal; A Jain; J Fung; S Todo; T E Starzl
Journal: Transplant Proc Date: 1990-02 Impact factor: 1.066

4. Pathologic observations in human allograft recipients treated with FK 506.

Authors: A J Demetris; J J Fung; S Todo; B Banner; T Zerbe; G Sysyn; T E Starzl
Journal: Transplant Proc Date: 1990-02 Impact factor: 1.066

5. FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication.

Authors: P B Carroll; H Rilo; J Reyes; R Alejandro; Y Zeng; C Ricordi; A Tzakis; R Shapiro; T E Starzl
Journal: Transplant Proc Date: 1991-12 Impact factor: 1.066

6. Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience.

Authors: K Abu-Elmagd; S Todo; J Fung; J Demetris; J Rakela; A S Rao; S Iwatsuki; T Starzl
Journal: Clin Transpl Date: 1994

7. Immunosuppressive activity of FK-506 in rats: flow cytometric analysis of lymphocyte populations in blood, spleen and thymus during treatment and following drug withdrawal.

Authors: J Woo; C S Ross; J I Milton; A W Thomson
Journal: Clin Exp Immunol Date: 1990-01 Impact factor: 4.330

8. Effects of a novel immunosuppressive agent, FK506, on human B cell activation.

Authors: N Suzuki; T Sakane; T Tsunematsu
Journal: Clin Exp Immunol Date: 1990-02 Impact factor: 4.330

9. Influence of FK506 and cyclosporin A on alloantibody production and lymphocyte activation following blood transfusion.

Authors: J Woo; D J Propper; A M Macleod; A W Thomson
Journal: Clin Exp Immunol Date: 1990-12 Impact factor: 4.330

10. Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction.

Authors: S Todo; Y Ueda; J A Demetris; O Imventarza; M Nalesnik; R Venkataramanan; L Makowka; T E Starzl
Journal: Surgery Date: 1988-08 Impact factor: 3.982